Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Florida Doctor Pays $750,000 to Settle Allegation of Medicare Fraud, Sheller Law Firm Represents Whistleblowers
  • USA - English


News provided by

Sheller, P.C.

Feb 28, 2014, 08:50 ET

Share this article

Share toX

Share this article

Share toX

Sheller, P.C. logo
Sheller, P.C. logo

Philadelphia, PA (PRWEB) February 28, 2014 -- Sheller, P.C. law firm announces that Sarasota Pain Associates, P.A. (SPA) and its owner, Dr. Steven Chun, have agreed to pay $750,000 to resolve allegations by the law firm’s whistleblower clients that SPA violated the False Claims Act by submitting Medicare claims for procedures and services that he did not perform. During the time in question, SPA operated its pain management practice in Sarasota, Florida, and then in Bradenton. 

McCormick in Law 360 said his clients were pleased with the settlement . . . due to its provisions stopping the alleged false billing, noting Chun would be subject to the "pretty strict guidelines" of the integrity agreement.

Post this

According to the U.S. Department of Justice (DOJ) in the case U.S. ex rel. Gavin v. Sarasota Pain Associates, P.A. and Steven Y. Chun, M.D., 6:11-cv-583-T-23TBM (M.D. Fla.), the allegations of Medicare fraud were raised in a lawsuit filed by Cathia Gavin and Penelope Thomas who both formerly worked as nurses for Dr. Chun.

The whistleblower-relators were represented by attorneys Stephen A. Sheller and Brian J. McCormick, Jr. of Sheller, P.C. in Philadelphia, as well as Joseph A. Trautwein of Blue Bell, Pennsylvania, and Mary Ann Floyd, of Diez and Floyd, P.A., Englewood, Florida.  According to court documents, relators Thomas and Gavin filed a whistleblower lawsuit under seal in the United States District Court for the Middle District of Florida in 2011. 

The lawsuit alleges that Dr. Chun and Sarasota Pain Associates knowingly submitted false claims for payment for patient evaluation, management services billed at a higher level and rate, and unnecessary and unrendered procedures which were paid by Medicare and Medicaid, in violation of the False Claims Act.  Additional charges included refills of implantable infusion pumps as if performed by a physician, when they were performed by a nurse, and injections that were not given. The United States joined their lawsuit on January 17, 2014.

In the DOJ report of the settlement, Dr. Chun and SPA have agreed to enter into an Integrity Agreement with the U.S. Department of Health and Human Services, Office of Inspector General, which requires Dr. Chun to attend training courses provided by the Center for Medicare Services and to conduct an independent external review of his coding and billing processes.

McCormick, in an interview with LexisNexis Law 360, said his clients were pleased with the settlement, most of all due to its provisions stopping the alleged false billing, noting Chun would be subject to some "pretty strict guidelines" under his integrity agreement.

The settlement stems from the whistleblower complaint pursuant to the qui tam provisions of the False Claims Act, which permits private persons with insider knowledge of fraud, waste and abuse to bring a lawsuit on behalf of the government and to share in the proceeds of the recovered stolen funds. The Act also permits the government to intervene in the lawsuit and take over the allegations. These statutes allow governments to recover three times the amount they were defrauded, in addition to civil penalties of $5,500 to $11,000 per false claim. Successful whistleblowers can receive between 15 and 30 percent of the governments’ recovery.

The DOJ says the settlement was achieved through the coordinated efforts of a team of attorneys from the U.S. Department of Justice and the U.S. Attorney’s Office for the Middle District of Florida. The team was led by Randy Harwell, Chief of the Civil Division and Assistant U.S. Attorney Kathy Ho, both  the U.S. Attorney’s Office from the Middle District of Florida. 

In the interview with Law 360, McCormick praised the attorneys and investigators in the case, saying they had done a “superb” job, giving Chun little choice but to settle the case. "The U.S. Attorney’s Office in Tampa did a fantastic job,” said McCormick. “Randy Harwell, Kathy Ho and Special Agent Ian Ives of the Office of Inspector General for HHS should be commended for their tireless work on this case.”

About Sheller, P.C.

Sheller, P.C. represents plaintiffs injured by defective drugs, devices, and consumer products nationwide as well as whistleblowers reporting corporate and government fraud. In practice since 1977, Sheller, P.C. has challenged some of the largest corporations in the United States, including pharmaceutical and medical device companies, auto, tobacco and others. The firm also represents whistleblowers in federal and state False Claims Act matters, including pharmaceutical qui tam matters that have recovered more than $6.2 billion for the U.S. Government to date, including some of the largest in U.S. history.(1,2,3,4,5)

(1) United States ex. rel. Victoria Starr, et al. v. Janssen Pharmaceutica Prods., L.P., No. 04-1529
(2) United States ex. rel. Robert Rudolph, et al. v. Eli Lilly and Company, No. 03-943
(3) United States ex. rel. Ronald Rainero, et al. v. Pfizer, Inc., No. 07-11728
(4) United States ex. rel. James Wetta, et al. v. AstraZeneca Corp., No. 04-0379 
(5) Price v. Philip Morris USA, 848 N.E.2d 1 (Ill. 2005)

Brian J. McCormick, Jr., Esq., Sheller, P.C., http://sheller.com, +1 215-790-7300, [email protected]

Modal title

Stephen A. Sheller, Esq.
Stephen A. Sheller, Esq.
Brian J. McCormick, Jr, Esq.
Brian J. McCormick, Jr, Esq.
Stephen A. Sheller, Esq. Brian J. McCormick, Jr, Esq.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.